Male lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH).
about
Effects of low-frequency ultrasound combined with microbubbles on benign prostate hyperplasia.Validation and reliability of a smartphone application for the International Prostate Symptom Score questionnaire: a randomized repeated measures crossover studyThe Efficacy and Safety of Tadalafil 5 mg Once Daily in Korean Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: An Integrated AnalysisNonspecific genitourinary pain improves after prostatectomy using holmium laser enucleation of prostate in patients with benign prostatic hyperplasia: a prospective study.Qianliening capsule inhibits benign prostatic hyperplasia angiogenesis via the HIF-1α signaling pathway.A Hoxb13-driven reverse tetracycline transactivator system for conditional gene expression in the prostate.Inhibitory effect of Yukmijihwang-tang, a traditional herbal formula against testosterone-induced benign prostatic hyperplasia in rats.Silodosin in the treatment of the signs and symptoms of benign prostatic hyperplasia: profile report.New clinical evidence of silodosin, an α(1A) selective adrenoceptor antagonist, in the treatment for lower urinary tract symptoms.New developments in the use of prostatic stentsAndrogens and estrogens in benign prostatic hyperplasia: past, present and future.Genetic Determinants of Metabolism and Benign Prostate Enlargement: Associations with Prostate Volume.Lower Urinary Tract Symptoms and Risk of Bladder Cancer in Men: Results From the Health Professionals Follow-up StudymiRNA Regulation Network Analysis in Qianliening Capsule Treatment of Benign Prostatic Hyperplasia.The impact of surgical treatments for lower urinary tract symptoms/benign prostatic hyperplasia on male erectile function: A systematic review and network meta-analysis.Quantification of Arachidonic Acid and Its Metabolites in Rat Tissues by UHPLC-MS/MS: Application for the Identification of Potential Biomarkers of Benign Prostatic HyperplasiaEffects of flavocoxid, a dual inhibitor of COX and 5-lipoxygenase enzymes, on benign prostatic hyperplasia.Association between polymorphisms of estrogen receptor 2 and benign prostatic hyperplasia.Evaluation of biomaterials for bladder augmentation using cystometric analyses in various rodent modelsSex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartmentComparative effects of Yi Jin Jing versus Tai Chi exercise training on benign prostatic hyperplasia-related outcomes in older adults: study protocol for a randomized controlled trialDifferential expression of androgen, estrogen, and progesterone receptors in benign prostatic hyperplasiaThe effect of a 6 Fr catheter on flow rate in men.Further evidence of endogenous hydrogen sulphide as a mediator of relaxation in human and rat bladder.Impact of partial urethral obstruction on bladder function: time-dependent changes and functional correlates of altered expression of Ca²⁺ signaling regulators.Silodosin: treatment of the signs and symptoms of benign prostatic hyperplasia.Combination pharmacological therapies for the management of benign prostatic hyperplasia.Self-report measurement of lower urinary tract symptoms: a commentary on the literature since 2011.Selective estrogen receptor modulators for BPH: new factors on the ground.The diagnosis and treatment of lower urinary tract symptoms due to benign prostatic hyperplasia with α-blockers: focus on silodosin.New intraprostatic injectables and prostatic urethral lift for male LUTS.Health-related quality of life and psychological well-being in men with benign prostatic hyperplasia: An integrative review.Antiproliferative and Antioxidant Effects of Withania coagulans Extract on Benign Prostatic Hyperplasia in Rats.Serenoa repens, selenium and lycopene to manage lower urinary tract symptoms suggestive for benign prostatic hyperplasia.Inhibitors of apoptosis proteins in experimental benign prostatic hyperplasia: effects of serenoa repens, selenium and lycopene.Urolift: a New Face of Minimally Invasive Surgical Technique for Benign Prostatic Hyperplasia?Efficacy and Safety of Dutasteride in Chinese Adults with Symptomatic Benign Prostatic Hyperplasia : A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study with an Open-Label Extension.How Readable Is BPH Treatment Information on the Internet? Assessing Barriers to Literacy in Prostate Health.Prostatic Urethral Lift Versus Transurethral Resection of the Prostate (TURP).Evaluation of hyoscine N-butyl bromide efficacy on the prevention of catheter-related bladder discomfort after transurethral resection of prostate: a randomized, double-blind control trial.
P2860
Q30446785-12E6BBCF-D20E-4BCD-94A1-35AA879A838EQ33440575-B4C5D7C7-0706-41E8-BED8-BA20F017E6DDQ33632142-E94EB448-31B5-4E77-8B62-F4EAAC9F40A5Q33717126-F615943A-74E5-49C1-B09E-E82A3DEAD786Q33769561-87A82D48-FBF2-4BED-A1D9-2F6F2E4036ADQ34049857-19AF2069-A347-4B6C-B888-CA8980BFA8EDQ34240687-CBDB6911-D2C8-4293-9086-47281A95BE57Q34632828-97B6D442-838D-449E-AD42-38412E832C7DQ34635165-E9F6F5B9-15C0-4BE4-B5FF-CC8F4A1218D4Q35033348-6946006C-50F1-4A09-AD26-FE0C38C7AD57Q35231660-7206F7DE-B252-4E96-894A-65CEF99AFA48Q35687087-6850D9A7-8381-4083-AB25-07D34D826701Q35778734-28CF9430-38C9-4789-A9E2-BD0EF8026083Q35947195-539F0C1B-2623-4834-87B5-1EFD8E16F64BQ36054510-3A46CDD5-6890-463A-995F-08DDCB43F26DQ36205437-0BF07E85-ABA4-489E-98E1-FD91E5C3693EQ36252843-75949DA2-25C3-46BF-83DE-073AF0C08B07Q36335781-1293097F-8636-423F-BA90-43BE8D36B45BQ36364684-DC91933E-BF3E-40F8-89A9-AB10B39999A4Q37060725-645C98B0-A098-4E24-85F6-74AB30A65F25Q37099684-24BEBA23-6C92-4069-87F0-808DD5860BB6Q37161245-3BC45997-81BE-45AD-8625-5E9D6E86A8DDQ37330811-893EDBDB-5D01-4ABF-8EFD-B4AA1B7FAB6BQ37437017-117ABF5D-92C0-4447-8A02-0132EE2F79B9Q37655877-27288386-432B-497F-A129-F5B2C0FA9587Q37875062-C4465411-D86B-48ED-96F5-3F5F71AF50D2Q37994725-B44D5B9A-4AB1-406D-8EBD-882A0A6016C3Q38051160-9C4F40C5-B4BE-4DB4-90A9-E7A6A19F3205Q38115066-8FCFEC4B-5F4F-48F9-A9F7-45914E05E022Q38364582-2AAAF540-2253-4307-9D38-181F5A22B07AQ38551294-91FB602A-EC90-47D5-8857-353EBE42B04AQ38702302-BFC4A159-B35D-4E1A-A10C-0CD0E14C1670Q38797324-DD2CF26F-7987-476B-BDC8-76999C01EED7Q38845916-048A5E3F-0A34-49BF-8131-0F6546B0FCE2Q38901253-B5785DD4-CD95-4230-BE95-0F1E29E3607AQ38901794-A5701D2B-0097-43D4-AED8-12A82C78FF58Q39116956-06CDBD1C-761D-49D3-BD38-45BFF6DC6E43Q39141309-26E9E5F5-5936-4DFF-9758-AD9D68F8538CQ39150636-11D21802-6871-4956-B1CC-2DD91091E0EBQ39151354-321DD4D7-0BCF-4929-AE9C-4F6471BACAD9
P2860
Male lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Male lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH).
@en
Male lower urinary tract symptoms
@nl
type
label
Male lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH).
@en
Male lower urinary tract symptoms
@nl
prefLabel
Male lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH).
@en
Male lower urinary tract symptoms
@nl
P1476
Male lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH).
@en
P2093
Claus G Roehrborn
P304
P356
10.1016/J.MCNA.2010.08.013
P577
2011-01-01T00:00:00Z